亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

供應(yīng)咪唑

 
 
單價(jià) 面議對(duì)比
詢價(jià) 暫無
發(fā)貨 河北廊坊市付款后3天內(nèi)
庫存 100噸起訂1噸
型號(hào) 288-32-4
規(guī)格 國標(biāo)
過期 長期有效
更新 2012-09-14 08:43
 

廊坊市燁聯(lián)商貿(mào)有限公司

企業(yè)會(huì)員第14年
資料未認(rèn)證
保證金未繳納
詳細(xì)說明

英文名稱:Imidazole
化學(xué)名稱: 1,3-二氨雜環(huán)戊二烯
分子式:C3H4N2
分子量:68.08
CAS No. 288-32-4
產(chǎn)品指標(biāo):
項(xiàng)    目(project
    標(biāo)(index
外觀(appearance
白色結(jié)晶
含量%content
99.5
水分%water content
0.2
熔點(diǎn)oCM.P.
88-91
物化性能:白色結(jié)晶,含量99.5%,易溶于水、醇、醚、氯仿、吡啶,微溶于苯,難溶于石油醚。有毒。對(duì)皮膚、粘膜有刺激性和腐蝕性。
用途:本產(chǎn)品主要作為醫(yī)藥工業(yè)的中間體,用于制備克霉唑、唑康唑、益康唑、酮康唑等抗真菌藥物;作為環(huán)氧樹脂的固化劑;作為咪唑衍生物甘寶素、羥基二咪唑等的原料。
包裝:內(nèi)襯雙層塑料袋,外用紙袋包裝,每袋凈重25kg。
舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
供應(yīng)吡啶硫酮銅 供應(yīng)吡啶硫酮鋅 供應(yīng)氫化鋁鋰 供應(yīng)氫化鈉 供應(yīng)氫化鈣 供應(yīng)氫化鋰 供應(yīng)吡啶硫酮鋅(ZPT) 供應(yīng)吡啶硫酮銅(CuPT)
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |